Implications of Cellular Senescence in Tissue Damage Response, Tumor Suppression, and Stem Cell Biology
Open accessAbstract
Cellular senescence is characterized by an irreversible cell cycle arrest that, when bypassed by mutation, contributes to cellular immortalization. Activated oncogenes induce a hyperproliferative response, which might be one of the senescence cues. We have found that expression of such an oncogene, Akt, causes senescence in primary mouse hepatoblasts in vitro. Additionally, AKT-driven tumors undergo senescence in vivo following p53 reactivation and show signs of differentiation. In another in vivo system, i.e., liver fibrosis, hyperproliferative signaling through AKT might be a driving force of the senescence in activated hepatic stellate cells. Senescent cells up-regulate and secrete molecules that, on the one hand, can reinforce the arrest and, on the other hand, can signal to an innate immune system to clear the senescent cells. The mechanisms governing senescence and immortalization are overlapping with those regulating self-renewal and differentiation. These respective control mechanisms, or their disregulation, are involved in multiple pathological conditions including fibrosis, wound healing, and cancer. Understanding extracellular cues that regulate these processes may enable new therapies for these conditions.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 63 cited sources checked · 0 supported · 0 flagged
- Findingcitation
These immune cells were often in close proximity to cells expressing the senescent markers p53, p21, and Hmga1.
“These immune cells were often in close proximity to cells expressing the senescent markers p53, p21, and Hmga1 (Krizhanovsky et al. 2008).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Krizhanovsky et al. 2008
Not checked in the free run.
- Findingown data
Dox-induced p53 reactivation in these tumors resulted in tumor regression.
“Addition of Dox and p53 reactivation resulted in tumor regression.”
Quote in the paperSubstantial claim - Findingcitation
p53−/−;INK4a/ARF−/− activated stellate cells display increased BrdU incorporation compared to wild-type cells.
“Moreover, p53−/−;INK4a/ARF−/− cells display increased bromodeoxyuridine (BrdU) incorporation compared to wild-type cells (Krizhanovsky et al. 2008).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Krizhanovsky et al. 2008
Not checked in the free run.
- Findingown data
Senescence protects against liver fibrosis partly by stimulating immune clearance of senescent cells.
“Although our results suggest that senescence protects against liver fibrosis, in part, by stimulating clearance of these cells by the immune systems”
Quote in the paperSubstantial claim - Findingcitation
In fibrotic livers from CCl4-treated mice, lymphocytes (including NK cells), macrophages, and neutrophils were detected adjacent to hepatic stellate cells.
“Using a combination of electron microscopy and immunophenotying by immunofluorescence, we noted that lymphocytes (including NK cells), macrophages, and neutrophils were detected adjacent to HSCs in fibrotic livers from CCl4-treated mice (Fig. 5A) (Krizhanovsky et al. 2008).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Krizhanovsky et al. 2008
Not checked in the free run.
- Findingcitation
In a mouse HCC model, p53 shRNA knockdown led to hepatocarcinoma development when triple-transduced hepatoblasts were transplanted into recipient mice.
“In the absence of doxycycline (Dox), p53 shRNA knocked down p53 expression efficiently and led to hepatocarcinoma development when the triple-transduced cells were transplanted into recipient mice (Xue et al. 2007).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Xue et al. 2007
Not checked in the free run.
- Findingown data
CK8 was induced following p53 reactivation in tumors expressing activated Akt.
“Similarly, CK8 was induced following p53 reactivation in tumors expressing activated Akt (Fig. 1B).”
Quote in the paperSubstantial claim - Findingcitation
Cells in the region adjoining fibrotic scars express the senescence markers p16, p53, p21, and Hmga1.
“We find that cells in this region express senescence markers p16, p53, p21, and Hmga1 (Krizhanovsky et al. 2008).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Krizhanovsky et al. 2008
Not checked in the free run.
- Findingown data
SA-β-gal-positive cells were predominantly found in areas adjoining fibrotic scars, the site of hepatic stellate cell proliferation, migration, and fibrotic extracellular matrix production.
“Cells that stained positively for the senescence marker SA-β-gal were predominantly found in the areas adjoining fibrotic scars, the site of HSC proliferation, migration, and fibrotic ECM production (Fig. 2B).”
Quote in the paperSubstantial claim - Findingown data
CCl4 treatment for 6 weeks induced a distinctive fibrotic morphology and extracellular matrix accumulation in mouse livers.
“Livers from mice treated with CCl4, but not vehicle, showed a distinctive fibrotic morphology and accumulated ECMin the fibrotic scars (Fig. 2B).”
Quote in the paperSubstantial claim - Findingcitation
Senescence markers p53 and Hmga1 were expressed in cells positive for αSMA and Desmin, markers of activated stellate cells.
“the senescence markers p53 and Hmga1 were expressed in cells that were positive for αSMA and Desmin, markers of activated stellate cells (Krizhanovsky et al. 2008).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Krizhanovsky et al. 2008
Not checked in the free run.
- Findingcitation
Phosphorylated AKT was detected in a proportion of late-passage human activated stellate cells in culture.
“when we propagated human activated stellate cells in culture, phosphorylated AKT was detected in a proportion of late-passage cells (Krizhanovsky et al. 2008).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Krizhanovsky et al. 2008
Not checked in the free run.
- Findingcitation
Similar senescent cells were observed in livers from human patients with liver fibrosis.
“Similar cells were also observed in livers from human patients with liver fibrosis (Krizhanovsky et al. 2008).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Krizhanovsky et al. 2008
Not checked in the free run.
- Findingown data
In Akt-transduced hepatoblasts with conditional p53 repression, p53 suppression led to aggressive liver carcinomas.
“In the absence of Dox, expression of p53 was suppressed, leading to the development of aggressive liver carcinomas.”
Quote in the paperSubstantial claim - Findingown data
Elevated levels of active phosphorylated AKT (Ser-473) were detected in αSMA-positive cells in fibrotic livers but not in control livers.
“elevated levels of an active phosphorylated AKT (Ser-473) were detected in cells positive for the stellate cell marker αSMA in fibrotic livers but not control livers (Fig. 4).”
Quote in the paperSubstantial claim - Findingown data
Senescence protects against tissue injury by restricting proliferation of activated stellate cells after acute injury, thereby reducing associated fibrosis.
“our recent results show that senescence can act as a protective mechanism during tissue injury, in particular, by limiting the proliferation of activated stellate cells in response to acute injury and thus the associated fibrosis.”
Quote in the paperSubstantial claim - Findingreasoning
Hepatoblasts with hyperactive Akt are prone to senescence when p53 is present.
“hepatoblasts expressing hyperactive Akt—a key mediator of PI3K signaling—are prone to senescence in the presence of p53”
Quote in the paperSubstantial claim - Findingcitation
The p53 reactivation-induced senescence program is accompanied by differentiation markers.
“this program is accompanied by the appearance of differentiation markers (see Fig. 1) (Xue et al. 2007).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Xue et al. 2007
Not checked in the free run.
- Findingown data
DNA-damage foci are present in cells next to the fibrotic scar.
“have noted DNA-damage foci present in cells adjacent to the fibrotic scar (data not shown).”
Quote in the paperNot a substantial claim - Findingreasoning
Carcinomas caused by Akt and p53 loss undergo senescence when p53 signaling is restored.
“carcinomas induced by Akt and p53 loss undergo senescence when p53 signaling is restored.”
Quote in the paperSubstantial claim - Findingown data
Senescent stellate cells show increased PI3K signaling.
“we see up-regulation of PI3K signaling in senescent stellate cells”
Quote in the paperSubstantial claim - Findingcitation
Reactivation of p53 in HrasV12 and Akt-expressing tumors drives a cell cycle arrest program with many senescence hallmarks.
“reactivation of p53 in HrasV12 and Akt-expressing tumors drives a cell cycle arrest program with many hallmarks of senescence”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Xue et al. 2007
Not checked in the free run.
- Premisecitation
Many cell types can enter senescence in response to various forms of cellular damage or stress.
“senescence can be triggered in many cell types in response to diverse forms of cellular damage or stress (Serrano et al. 1997; Campisi and d’Adda di Fagagna 2007).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Serrano et al. 1997
Not checked in the free run.
- cites Campisi and d’Adda di Fagagna 2007
Not checked in the free run.
- Premisecitation
Hyperactivation of the PI3K pathway, for example by Akt deregulation, together with p53 loss can promote hepatocellular carcinoma development.
“We have previously shown that hyperactivation of the PI3K pathway, for example, by deregulation of Akt, together with p53 loss could promote hepatocellular carcinoma development (Zender et al. 2006).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Zender et al. 2006
Not checked in the free run.
- Interpretationreasoning
Immune cells are localized adjacent to senescent activated stellate cells in fibrotic liver.
“Therefore, immune cells are localized adjacent to senescent activated stellate cells in fibrotic liver.”
Quote in the paperSubstantial claim - Interpretationreasoning
Senescence of activated stellate cells in wild-type mice protects the liver from unlimited expansion of these cells and more severe fibrosis.
“Therefore, senescence of activated stellate cells in wild-type mice protects the liver from unlimited expansion of these cells and more severe fibrosis.”
Quote in the paperSubstantial claim - Interpretationown data
p53−/−;INK4a/ARF−/− activated stellate cells are immortalized in vitro.
“These results demonstrate that p53−/−;INK4a/ARF−/−-activated stellate cells are immortalized in vitro.”
Quote in the paperSubstantial claim - Premisecitation
Senescent cells activate the p53 and p16/Rb tumor suppressor pathways.
“senescent cells activate the p53 and p16/Rb (retinoblastoma) tumor suppressor pathways (Mooi and Peeper 2006; Campisi and d’Adda di Fagagna 2007; Collado et al. 2007).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Mooi and Peeper 2006
Not checked in the free run.
- cites Campisi and d’Adda di Fagagna 2007
Not checked in the free run.
- cites Collado et al. 2007
Not checked in the free run.
- Premisecitation
Oncogene-induced senescence is an important tumor suppressor mechanism that constrains tumorigenesis in multiple human and mouse cancers.
“this “oncogene-induced senescence” has been established as an important tumor suppressor mechanism that constrains tumorigenesis in multiple forms of cancer in humans and mice.”
Quote in the paperSubstantial claim - Premisecitation
Several activated oncogenes can induce senescence, partly through signals from DNA damage or replicative stress.
“Several activated oncogenes can induce senescence, in part, through signals initiated by DNA damage or replicative stress.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Serrano et al. 1997
Not checked in the free run.
- Premisecitation
In cancer, senescence can serve as a tumor suppressor mechanism in multiple ways.
“In cancer, senescence can serve as a tumor suppressor mechanism in multiple ways.”
Quote in the paperSubstantial claim - Interpretationcitation
Along with induction of senescence, tumors show signs of differentiation following p53 reactivation.
“Therefore, along with induction of senescence, tumors show signs of differentiation following p53 reactivation.”
Quote in the paperSubstantial claim - Interpretationown data
Akt expression induces senescence in a p53-dependent manner.
“These results suggest that Akt expression induces senescence in a manner that is dependent on p53.”
Quote in the paperSubstantial claim - Interpretationown data
The innate immune system can contribute to the elimination of senescent stellate cells from the fibrotic liver.
“Therefore, the innate immune system can contribute to the elimination of senescent stellate cells from the fibrotic liver.”
Quote in the paperSubstantial claim - Interpretationown data
Akt-transformed hepatoblasts undergo senescence in vivo upon p53 reactivation, similar to tumors expressing oncogenic HrasV12.
“Therefore, like tumors expressing oncogenic HrasV12, Akt-transformed hepatoblasts undergo senescence in vivo upon p53 reactivation.”
Quote in the paperSubstantial claim - Premisecitation
Xenotransplant experiments mixing normal and senescent cells indicate that senescent cells can promote transformation of premalignant epithelial cells.
“In fact, xenotransplant studies mixing normal and senescent cells suggest that senescent cells can stimulate the transformation of premalignant epithelial cells (Krtolica et al. 2001).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Krtolica et al. 2001
Not checked in the free run.
- Interpretationreasoning
Senescent activated stellate cells are present in chemically induced fibrotic livers in mice.
“Therefore, senescent activated stellate cells are present in chemically induced fibrotic livers in mice.”
Quote in the paperSubstantial claim - Premisereasoning
Senescence plays an important role in tumor suppression.
“Consistent with its function in halting cellular proliferation, senescence also has an important role in tumor suppression.”
Quote in the paperSubstantial claim - Premisecitation
Upon tumor presentation, senescence can be induced in some tumor cells by chemotherapy agents.
“Second, upon tumor presentation, senescence can be induced in some tumor cells by chemotherapy agents (Schmitt et al. 2002).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Schmitt et al. 2002
Not checked in the free run.
- Interpretationcitation
The senescence machinery can remain intact in advanced cancers, where it remains capable of halting proliferation of tumor cells or cells carrying a strong oncogenic signal.
“Therefore, the senescence machinery can remain intact in advanced cancers, where it remains capable of halting proliferation of tumor cells or cells carrying a strong oncogenic signal.”
Quote in the paperSubstantial claim - Premisecitation
In liver carcinomas expressing oncogenic ras, the onset of cellular senescence correlated with the appearance of differentiation markers.
“In liver carcinomas expressing oncogenic ras, the onset of cellular senescence correlated with the appearance of differentiation markers (Xue et al. 2007).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Xue et al. 2007
Not checked in the free run.
- Interpretationown data
The senescence of activated stellate cells is triggered by a hyperproliferative signal mediated at least in part by AKT.
“These results are consistent with the possibility that the senescence of activated stellate cells is triggered by a hyperproliferative signal mediated, at least in part, by AKT.”
Quote in the paperSubstantial claim - Premisenone given
Upon liver injury, signaling from damaged hepatocytes activates hepatic stellate cells, causing proliferation, migration, extracellular matrix deposition, and fibrotic scar formation.
“Upon liver injury, signaling from damaged hepatocytes leads to HSC activation, resulting in intensive proliferation of HSCs, migration from their normal location, ECM deposition, and formation of fibrotic scars.”
Quote in the paperNot a substantial claim - Premisecitation
Senescent cells lower extracellular matrix deposition by reducing matrix component production and increasing matrix-degrading enzymes.
“In addition, senescent cells decrease production of components of the ECM and up-regulate ECM degrading enzymes, thus decreasing the amount of deposited matrix.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Krizhanovsky et al. 2008
Not checked in the free run.
- Interpretationreasoning
Recruitment of immune cells by senescent activated stellate cells may, after initially helping, promote chronic inflammation that drives malignant hepatocyte emergence and cancer progression.
“the contribution of senescent activated stellate cells in recruiting immune cells, although initially beneficial, may ultimately contribute to chronic inflammation that stimulates the emergence of malignant hepatocytes and cancer progression.”
Quote in the paperSubstantial claim- Rests on an assumption: Chronic inflammation from viruses, alcohol abuse, or nonalcoholic steatohepatitis is required for hepatocellular carcinoma in humans.
- Premisecitation
Senescent cells often up-regulate inflammatory cytokines and other molecules that modulate the microenvironment or immune response.
“senescent cells often up-regulate inflammatory cytokines and other molecules known to modulate the microenvironment or immune response (Campisi and d’Adda di Fagagna 2007).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Campisi and d’Adda di Fagagna 2007
Not checked in the free run.
- Premisecitation
p53 promotes senescence by trans-activating genes that inhibit proliferation, including p21/Cip1/Waf1 and miR-34 microRNAs.
“p53 promotes senescence by trans-activating genes that inhibit proliferation, including the p21/Cip1/Waf1 cyclin-dependent kinase inhibitor and miR-34 class of microRNAs (He et al. 2007a).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites He et al. 2007a
Not checked in the free run.
- Premisecitation
Secreted proteins from senescent cells can modulate the cell cycle exit program in an autocrine manner to some degree.
“to at least some degree, these secreted proteins modulate the cell cycle exit program itself in an autocrine manner (Acosta et al. 2008; Kuilman et al. 2008; Wajapeyee et al. 2008).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Acosta et al. 2008
Not checked in the free run.
- cites Kuilman et al. 2008
Not checked in the free run.
- cites Wajapeyee et al. 2008
Not checked in the free run.
- Premisecitation
Wnt signaling controls self-renewal and differentiation of stem cells from multiple origins.
“Wnt signaling, which controls self-renewal and differentiation of stem cells from multiple origins (Reya and Clevers 2005)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Reya and Clevers 2005
Not checked in the free run.
- Interpretationreasoning
Senescence limits tumorigenesis or tissue damage through mechanisms that go beyond cell-autonomous cell cycle arrest.
“It is now clear that the way in which senescence suppresses tumorigenesis or limits tissue damage extends beyond a cell-autonomous cell cycle arrest for which the program is best known.”
Quote in the paperSubstantial claim - Premisecitation
ARF locus disruption is sufficient to give cancer stem cell properties to nearly all lymphoid cells expressing Bcr-Abl.
“disruption of the ARF locus, well established to facilitate cellular immortalization, is sufficient to confer “cancer stem cell” properties to virtually all lymphoid cells expressing Bcr-Abl (Williams and Sherr 2008).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Williams and Sherr 2008
Not checked in the free run.
- Premisecitation
Wnt signaling can facilitate immortalization in primary melanocytes.
“can facilitate immortalization in primary melanocytes (Delmas et al. 2007).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Delmas et al. 2007
Not checked in the free run.
- Premisecitation
Bmi-1 appears to promote stem cell self-renewal in multiple tissues.
“appears to promote stem cell self-renewal in a variety of tissues (Bruggeman et al. 2005; Gil et al. 2005; Molofsky et al. 2005).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Bruggeman et al. 2005
Not checked in the free run.
- cites Gil et al. 2005
Not checked in the free run.
- cites Molofsky et al. 2005
Not checked in the free run.
- Premisecitation
After liver injury, damaged hepatocytes release signals that cause massive expansion of normally quiescent stellate cells.
“it is well established that upon liver injury, damaged hepatocytes send signals that trigger the massive expansion of stellate cells that are normally quiescent in the intact liver (Bataller and Brenner 2005).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Bataller and Brenner 2005
Not checked in the free run.
- Premisecitation
The senescence-associated secretory phenotype stimulates immune targeting of senescent cells.
“this program stimulates the immune system to target senescent cells”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Xue et al. 2007
Not checked in the free run.
- cites Krizhanovsky et al. 2008
Not checked in the free run.
- Interpretationreasoning
Cellular immortalization resembles stem cell self-renewal, since both involve sustained cell division.
“In many ways, immortalization is similar to the process of cellular self-renewal, or the manner in which stem cells reproduce themselves, which is also a process of sustained cell division.”
Quote in the paperNot a substantial claim - Interpretationreasoning
The accumulation of senescent cells in tissues can be modulated from outside the cell.
“The fact that the accumulation of senescent cells in tissues can be modulated externally suggests therapeutic strategies to modulate senescence-associated pathologies.”
Quote in the paperSubstantial claim - Premisecitation
Systemic IGFBP7 delivery can suppress melanoma xenograft progression in mice.
“systemic delivery of the senescence inducer IGFBP7 can suppress the progression of melanoma xenografts in mice”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Wajapeyee et al. 2008
Not checked in the free run.
- Interpretationreasoning
It is likely that in many cases, cancer stem cell origin and self-renewal acquisition reflect the immortalization process studied for decades.
“from the discussion above, it seems likely that in many cases, this reflects the process of immortalization studied for the last 30 years.”
Quote in the paperSubstantial claim - Interpretationreasoning
Many processes currently called self-renewal have long been known to affect immortalization.
“many of the processes currently linked to “self-renewal” have long been established to influence immortalization.”
Quote in the paperSubstantial claim - Premisecitation
Quiescent hepatic stellate cells have stem cell properties, including the ability to proliferate and differentiate into multiple lineages.
“quiescent HSCs were recently reported to have stem cell properties, sharing the ability to proliferate and differentiate into multiple cell lineages (Yang et al. 2008).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Yang et al. 2008
Not checked in the free run.
- Interpretationreasoning
Stem cell self-renewal and cellular immortalization share molecular pathways that centrally regulate them.
“It is striking that the normal process of stem cell self-renewal and the aberrant process of cellular immortalization share molecular pathways that have a central role in their regulation (Fig. 7).”
Quote in the paperSubstantial claim - Interpretationreasoning
The overlap between immortalization and self-renewal applies to HCC progression and liver fibrosis.
“The overlaps between immortalization (or escape from senescence) and self-renewal (or suppression of differentiation) can be extended to the settings of HCC progression and liver fibrosis studied here.”
Quote in the paperSubstantial claim - Interpretationreasoning
The PI3K pathway can cause unrestricted proliferation followed by senescence in precancerous lesions.
“One of the pathways that can lead to unrestricted proliferation and subsequent senescence in precancerous lesions is the PI3K pathway.”
Quote in the paperSubstantial claim - Premisecitation
Bmi-1 promotes cellular immortalization by repressing the INK4a/ARF locus.
“the Polycomb repressor 2 complex protein Bmi-1 can promote cellular immortalization by suppressing the INK4a/ARF locus”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Bruggeman et al. 2005
Not checked in the free run.
- cites Gil et al. 2005
Not checked in the free run.
- cites Molofsky et al. 2005
Not checked in the free run.
- Interpretationreasoning
In liver fibrosis, activated stellate cells senesce after an initial proliferative burst, which may be considered terminal differentiation.
“in liver fibrosis following an initially proliferative burst, activated stellate cells eventually senesce, which might be viewed as a state of terminal differentiation.”
Quote in the paperNot a substantial claim - Premisecitation
Both self-renewal and immortalization have been linked to stem cell self-renewal in hematopoietic and neuronal systems.
“Both processes have been linked to self-renewal of stem cells in the hematopoietic and neuronal systems (Bruggeman et al. 2005; Molofsky et al. 2005)”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Bruggeman et al. 2005
Not checked in the free run.
- cites Molofsky et al. 2005
Not checked in the free run.
- Interpretationreasoning
The senescence-associated secretory phenotype has a major role in restricting cell accumulation in tissues.
“a non-cell-autonomous aspect of the program, the “senescence-associated secretory phenotype,” clearly has an important role in limiting the accumulation of cells in tissues.”
Quote in the paperSubstantial claim
- May combine two claims. 28
- Classified as probably not a substantial claim. 3
May combine two claims.
FindingcitationFollowing Dox treatment, p53 was induced, a substantial percentage of tumor cells became SA-β-gal positive, and tumors shrank and virtually disappeared after 20 days.
“Following Dox treatment, p53 was induced, and a substantial percentage of tumor cells became SA-β-gal positive (Fig. 1B); moreover, the tumors shrank and virtually disappeared after 20 days (Xue et al. 2007).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Xue et al. 2007
Not checked in the free run.
May combine two claims.
Findingown dataNumerous activated stellate cells were retained in anti-NK antibody-treated mice, while activated stellate cells were almost completely eliminated in polyI:C-treated mice.
“Numerous activated stellate cells were retained in the livers of anti-NK antibody-treated mice (Fig. 5B). In contrast, activated stellate cells were almost completely eliminated in the livers of polyI:C-treated mice.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataWild-type hepatoblasts infected with activated Akt exhibit flattened morphology and SA-β-gal positivity, whereas p53−/− hepatoblasts continue to proliferate and reach confluence.
“Hepatoblasts derived from wild-type embryos infected with Akt exhibit flattened morphology and stain positive for SA-β-gal, whereas p53−/− hepatoblasts continue to proliferate and easily reach confluence when seeded at low density (Fig. 1A).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataWild-type activated stellate cells eventually undergo senescence in vitro and do not form colonies, whereas p53−/−;INK4a/ARF−/− cells do not undergo senescence and continue to proliferate.
“Whereas wild-type cells eventually undergo senescence in vitro and do not form colonies, p53−/−;INK4a/ARF−/− cells do not undergo senescence and continue to proliferate (Fig. 3A).”
Quote in the paperSubstantial claimMay combine two claims.
FindingreasoningSenescent cells increase molecules that mediate immune interactions, which may lead to their later removal.
“Moreover, senescent cells up-regulate a wide array of molecules that mediate interactions with the immune system that, in turn, may signal their subsequent elimination.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataUntreated tumors remained SA-β-gal negative and continued to grow.
“In contrast, tumors present in untreated mice remained SA-β-gal negative and continued to grow.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataSenescent cells triggered an immune response in vivo, causing infiltration of immune cells into the tumor and clearance of senescent cells.
“Senescent cells triggered an immune response in vivo, resulting in infiltration of immune cells into the tumor and clearance of senescent cells.”
Quote in the paperSubstantial claimMay combine two claims.
Findingcitationp53 reactivation in tumor cells led to cellular senescence rather than apoptosis, and this was associated with markers of cellular differentiation.
“p53 reactivation in the tumor cells led to cellular senescence and not apoptosis, which was also associated with markers of cellular differentiation (see Figure S3 in Xue et al. 2007).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Xue et al. 2007
Not checked in the free run.
May combine two claims.
Findingnone givenWithin 20 days of stopping CCl4 treatment, liver fibrosis was almost resolved and senescent cells were not detected.
“Interestingly, within 20 days of stopping CCl4 treatment, liver fibrosis was almost resolved and senescent cells were not detected.”
Quote in the paperSubstantial claimMay combine two claims.
FindingcitationLivers from anti-NK antibody-treated mice retained more senescent cells and fibrosis than controls, whereas senescent cells and fibrosis were more rapidly cleared in livers from polyI:C-treated mice.
“Livers from mice treated with the anti-NK antibody retained more senescent cells and fibrosis than controls, whereas senescent cells and fibrosis were more rapidly cleared in livers from mice treated with polyI:C (Krizhanovsky et al. 2008).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Krizhanovsky et al. 2008
Not checked in the free run.
May combine two claims.
FindingcitationReactivation of the p53 pathway in tumors leads to activation of the senescence program and tumor clearance by the innate immune system in vivo.
“We have demonstrated that reactivation of the p53 pathway in tumors leads to activation of the senescence program and tumor clearance by the innate immune system in vivo (Xue et al. 2007).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Xue et al. 2007
Not checked in the free run.
May combine two claims.
FindingcitationLiver fibrosis was significantly more pronounced in p53−/−;INK4a/ARF−/− mice than in wild-type mice and was accompanied by a significant increase in αSMA expression.
“Liver fibrosis was significantly more pronounced in mutant p53−/−;INK4a/ARF−/− mice than in wild-type mice (Krizhanovsky et al. 2008) and was accompanied by a significant increase in the expression of the activated stellate cell marker αSMA (Fig. 3B) (see also Krizhanovsky et al. 2008).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Krizhanovsky et al. 2008
Not checked in the free run.
May combine two claims.
FindingcitationImmune targeting of senescent cells has a key role in tumor suppression and tissue fibrosis.
“our studies show that this targeting has a key role in tumor suppression and tissue fibrosis (Xue et al. 2007; Krizhanovsky et al. 2008).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Xue et al. 2007
Not checked in the free run.
- cites Krizhanovsky et al. 2008
Not checked in the free run.
Classified as probably not a substantial claim. May combine two claims.
PremisecitationSenescence is a stable or irreversible cell-cycle arrest that limits proliferative capacity and prevents immortalization.
“Cellular senescence is a stable formof a cell cycle arrest program that limits the proliferative potential of cells and thereby prevents immortalization.”
- Also stated in: § Abstract · plain
“Cellular senescence is characterized by an irreversible cell cycle arrest that, when bypassed by mutation, contributes to cellular immortalization.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Hayflick and Moorhead 1961
Not checked in the free run.
- Also stated in: § Abstract · plain
May combine two claims.
PremisecitationDNA damage is a potent trigger of senescence and is induced by telomere attrition during replicative exhaustion.
“One of the most potent triggers of senescence is DNA damage, which is induced by telomere attrition during replicative exhaustion (Vaziri et al. 1997).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Vaziri et al. 1997
Not checked in the free run.
May combine two claims.
Interpretationown dataLoss of a tumor suppressor may be required for maintenance of some tumors, and during senescence cell-autonomous and non-cell-autonomous processes cooperate to eliminate formerly malignant cells.
“These results suggest that loss of a tumor suppressor may be required for the maintenance of some tumors; moreover, during cellular senescence in this system, cell-autonomous processes and non-cell-autonomous processes cooperate to eliminate the formerly malignant cell.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningSenescence of activated stellate cells triggers a coordinated program that limits damage response by reducing cell number and matrix production while promoting repair by signaling elimination of senescent cells.
“Therefore, the senescence of activated stellate cells triggers a coordinated program that acts to inhibit the damage response by limiting the number of the cells and ECM production, on the one hand, and promoting tissue repair by signaling the elimination of senescence cells, on the other hand (Fig. 6).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationLiver fibrosis is characterized by extracellular matrix deposition by activated hepatic stellate cells, the main fibrogenic cell type in the liver.
“In biopsies, liver fibrosis is characterized by depositions of the extracellular matrix (ECM) known as fibrotic scars, which is deposited by activated hepatic stellate cells (HSCs), the main fibrogenic cell type in the liver.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Bataller and Brenner 2005
Not checked in the free run.
May combine two claims.
PremisecitationSenescent activated stellate cells up-regulate molecules involved in natural killer cell recognition and can be preferentially targeted by these cells in vitro.
“we have shown that senescent activated stellate cells up-regulate the expression of molecules involved in natural killer (NK) cell recognition and, furthermore, can be preferentially targeted by these cells in vitro (Krizhanovsky et al. 2008).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Krizhanovsky et al. 2008
Not checked in the free run.
May combine two claims.
PremisecitationSenescent cells display a large flattened shape and accumulate SA-β-gal activity, which distinguishes them from most quiescent cells.
“Senescent cells display a large flattened morphology and accumulate a senescence-associated β-galactosidase (SA-β-gal) activity distinguishing them from most quiescent cells (Campisi and d’Adda di Fagagna 2007).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Campisi and d’Adda di Fagagna 2007
Not checked in the free run.
May combine two claims.
Interpretationown dataSenescence acts as a tumor suppressive mechanism in liver carcinoma and as a program that limits liver fibrosis.
“Recently, we demonstrated that senescence functions as both a tumor suppressive mechanism in liver carcinoma and a program that limits liver fibrosis.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Xue et al. 2007
Not checked in the free run.
- cites Krizhanovsky et al. 2008
Not checked in the free run.
May combine two claims.
PremisecitationOncogene-induced senescence provides an initial barrier to malignancies in skin, prostate, hematopoietic and other systems, whereas telomere-based senescence may attenuate tumor progression.
“First, oncogene-induced senescence provides an initial barrier to the development of malignancies in skin, prostate, and hematopoietic and other systems, whereas telomere-based senescence may attenuate tumor progression (Narita and Lowe 2005).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Narita and Lowe 2005
Not checked in the free run.
May combine two claims.
InterpretationreasoningIf senescence processes occur in premalignant settings, senescence would limit tumorigenesis by preventing proliferation while exposing damaged cells to immune surveillance leading to their elimination.
“If these processes occur in premalignant settings, senescence would limit tumorigenesis by preventing proliferation while at the same time exposing the damaged cells to a form of immune surveillance leading to their elimination.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationThe signal triggering senescence likely involves INK4a/ARF activation and a DNA-damage response caused by replication stress.
“The nature of this signal is the topic of much debate and likely involves activation of the INK4a/ARF locus as well as a DNA-damage response through signals produced by replication stress (Bartkova et al. 2006; Di Micco et al. 2006).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Bartkova et al. 2006
Not checked in the free run.
- cites Di Micco et al. 2006
Not checked in the free run.
Probably not a substantial claim: may not pass S4 (based).
InterpretationreasoningThe overlaps may reflect mechanisms that first controlled cell numbers in normal tissues and were later co-opted into tumor suppressive mechanisms against uncontrolled division.
“these overlaps might have a deeper meaning, reflecting mechanisms that initially evolved to control cell numbers in normal tissues but were later incorporated into intrinsic tumor suppressive mechanisms to limit uncontrolled cell division.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationPTEN inactivation can trigger senescence and restrict hematopoietic stem cell self-renewal.
“inactivation of the PTEN tumor suppressor can trigger senescence and limits the self-renewal of hematopoietic stem cells (Yilmaz et al. 2006).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Yilmaz et al. 2006
Not checked in the free run.
May combine two claims.
InterpretationreasoningSenescence and immortalization, and differentiation and self-renewal, share signaling mechanisms and are two sides of one coin.
“the processes of senescence and immortalization, and differentiation and self-renewal, share overlapping signaling mechanisms and can be viewed as two sides of the same coin.”
Quote in the paperSubstantial claimMay combine two claims.
Premisecitationp16 accumulates in some stem cells with age and limits their self-renewal.
“p16 accumulates in certain stem cells with age and acts to limit self-renewal (Janzen et al. 2006; Krishnamurthy et al. 2006; Molofsky et al. 2006).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Janzen et al. 2006
Not checked in the free run.
- cites Krishnamurthy et al. 2006
Not checked in the free run.
- cites Molofsky et al. 2006
Not checked in the free run.
May combine two claims.
InterpretationcitationQuiescent hepatic stellate cells may act as regional multipotent progenitors that cannot self-renew but can differentiate into multiple lineages.
“These cells might serve as regional multipotent progenitors that are unable to self-renew but are able to differentiate into multiple lineages.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningThe decision to proliferate is controlled by multiple pathways that can support self-renewal or allow senescence bypass and immortalization.
“Thus, the critical cellular decision to proliferate is regulated by multiple pathways, which can positively affect self-renewal or enable bypass of senescence and facilitate cellular immortalization.”
Quote in the paperSubstantial claim
The paper relies on this without support.
The mouse models of hepatocellular carcinoma and liver fibrosis used in the study are representative of the corresponding human diseases.
“We previously used a mouse model of liver carcinoma to determine the consequence of reactivating the p53 pathway in liver tumors (Xue et al. 2007).”
“To investigate the role of cellular senescence in fibrosis progression, we induced fibrosis in mice by twice-weekly treatment with 1 ml/kg of CCl4 for 6 weeks (Fig. 2A).”
The paper relies on this without support.
The immune system's clearance of senescent cells observed in mice is a mechanism that can be generalized to humans.
“Therefore, the innate immune system can contribute to the elimination of senescent stellate cells from the fibrotic liver.”
The paper relies on this without support.
Chronic inflammation from viruses, alcohol abuse, or nonalcoholic steatohepatitis is required for hepatocellular carcinoma in humans.
“chronic inflammation produced by viruses, alcohol abuse, or nonalcoholic steatohepatitis is a prerequisite for the development of hepatocellular carcinoma in humans.”
The paper relies on this without support.
Oncogene activation or other hyperproliferative signals are key triggers of senescence in tumor suppression.
“one of the key triggers of senescence is oncogene activation or other signals that produce a hyperproliferative response.”
The paper relies on this without support.
Mutations that disable the senescence program promote cellular immortalization and eventually cancer.
“Mutations that disable the senescence program—for example, loss of p53, Rb, and IGFBP7 or overexpression of Bmi-1 and CBX7—facilitate cellular immortalization and ultimately cancer development.”
The paper relies on this without support.
INK4a/ARF locus gene products are key elements preventing cell immortalization.
“gene products of INK4a/ARF locus are established key elements in prevention of cell immortalization.”
The paper relies on this without support.
p16/INK4a inhibits cyclin-dependent kinases 2 and 4, preventing Rb phosphorylation and cell cycle progression.
“p16/INK4a inhibits cyclin-dependent kinases 2 and 4, thereby preventing Rb phosphorylation and cell cycle progression.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The proliferation and survival defects in late-generation telomerase-knockout mice are caused by a subset of critically short telomeres rather than by a reduction in mean telomere length.
“The defects in proliferation and survival seen in late-generation telomerase-knockout mice appear to be caused by a subset of critically short telomeres, rather than a reduction in mean telomere length.”
From Telomeres and telomerase in cancer (2010) · cites this paper as [68]
Cites
The serial cultivation of human diploid cell strains
Hayflick, L., & Moorhead, P. S. (1961) · Experimental Cell Research · doi:10.1016/0014-4827(61)90192-6 · Cited by 8,508 · see citing works
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,178 · cited 3× · see citing works
“Initially defined by the phenotype of human fibroblasts undergoing replicative exhaustion in culture (Hayflick and Moorhead 1961), senescence can be triggered in many cell types in response to diverse forms of cellular damage or stress (Serrano et al. 1997; Campisi and d’Adda di Fagagna 2007).”
BackgroundSelf-citationBataller, R., & Brenner, D. A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24282 · Cited by 4,958 · see citing works
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441 · see citing works
Wnt signalling in stem cells and cancer
Reya, T., & Clevers, H. (2005) · Nature · doi:10.1038/nature03319 · Cited by 3,666 · see citing works
A microRNA component of the p53 tumour suppressor network
He, L., He, X., Lim, L. P., de Stanchina, E., Xuan, Z., Liang, Y., Xue, W., Zender, L., Magnus, J., Ridzon, D., et al. (2007) · Nature · doi:10.1038/nature05939 · Cited by 2,692 · see citing works
Self-citationSenescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473 · see citing works
Self-citationRb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278 · cited 3× · see citing works
“Later, we studied the molecular mechanisms of senescence and implicated chromatin-modulating factors and the miR-34 family of microRNAs as key regulators of the senescence program (Narita et al. 2003, 2006; He et al. 2007b).”
BackgroundSelf-citationBRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160 · see citing works
Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
Kuilman, T., Michaloglou, C., Vredeveld, L. C. W., Douma, S., van Doorn, R., Desmet, C. J., Aarden, L. A., Mooi, W. J., & Peeper, D. S. (2008) · Cell · doi:10.1016/j.cell.2008.03.039 · Cited by 2,086 · cited 1× · see citing works
“…Department of Gastroenterology, Hepatology and Endocrinology, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany. hyperplasia of the pituitary gland (Lazzerini Denchi et al. 2005), skin carcinoma (Collado et al. 2005), and melanocytic lesions of UV-irradiated hepatocyte growth factor/ scatter…”
BackgroundSenescence of activated stellate cells limits liver fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.06.049 · Cited by 2,029 · see citing works
Self-citationSenescence of Activated Stellate Cells Limits Liver Fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.09.015 · Cited by 2,027
Self-citationCrucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
Chen, Z., Trotman, L. C., Shaffer, D., Lin, H.-K., Dotan, Z. A., Niki, M., Koutcher, J. A., Scher, H. I., Ludwig, T., Gerald, W., et al. (2005) · Nature · doi:10.1038/nature03918 · Cited by 1,993 · see citing works
Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., Vassiliou, L.-V. F., Kolettas, E., Niforou, K., Zoumpourlis, V. C., et al. (2006) · Nature · doi:10.1038/nature05268 · Cited by 1,986 · see citing works
Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication
Di Micco, R., Fumagalli, M., Cicalese, A., Piccinin, S., Gasparini, P., Luise, C., Schurra, C., Garre’, M., Giovanni Nuciforo, P., Bensimon, A., et al. (2006) · Nature · doi:10.1038/nature05327 · Cited by 1,821 · see citing works
Chemokine signaling via the CXCR2 receptor reinforces senescence
Acosta, J. C., O'Loghlen, A., Banito, A., Guijarro, M. V., Augert, A., Raguz, S., Fumagalli, M., Da Costa, M., Brown, C., Popov, N., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.038 · Cited by 1,801 · cited 4× · see citing works
“Recently, high-throughput genetic approaches have identified several secreted molecules that functionally contribute to senescence (Acosta et al. 2008; Kuilman et al. 2008; Wajapeyee et al. 2008).”
BackgroundInfluentialSelf-citationKrtolica, A., Parrinello, S., Lockett, S., Desprez, P.-Y., & Campisi, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211053698 · Cited by 1,730 · see citing works
Cellular senescence in cancer and aging.
Collado, M., Blasco, M. A., & Serrano, M. (2007) · Cell · doi:10.1016/j.cell.2007.07.003 · Cited by 1,708 · see citing works
Reversal of human cellular senescence: roles of the p53 and p16 pathways
Beauséjour, C. M., Krtolica, A., Galimi, F., Narita, M., Lowe, S. W., Yaswen, P., & Campisi, J. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg417 · Cited by 1,457 · see citing works
Self-citationPten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells
Yilmaz, Ö. H., Valdez, R., Theisen, B. K., Guo, W., Ferguson, D. O., Wu, H., & Morrison, S. J. (2006) · Nature · doi:10.1038/nature04703 · Cited by 1,272 · see citing works
Oncogene-induced senescence as an initial barrier in lymphoma development
Braig, M., Lee, S., Loddenkemper, C., Rudolph, C., Peters, A. H. F. M., Schlegelberger, B., Stein, H., Dörken, B., Jenuwein, T., & Schmitt, C. A. (2005) · Nature · doi:10.1038/nature03841 · Cited by 1,220 · see citing works
Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a
Janzen, V., Forkert, R., Fleming, H. E., Saito, Y., Waring, M. T., Dombkowski, D. M., Cheng, T., DePinho, R. A., Sharpless, N. E., & Scadden, D. T. (2006) · Nature · doi:10.1038/nature05159 · Cited by 1,106 · see citing works
Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach
Zender, L., Spector, M. S., Xue, W., Flemming, P., Cordon-Cardo, C., Silke, J., Fan, S.-T., Luk, J. M., Wigler, M., Hannon, G. J., et al. (2006) · Cell · doi:10.1016/j.cell.2006.05.030 · Cited by 1,065 · see citing works
Self-citationA Senescence Program Controlled by p53 and p16INK4a Contributes to the Outcome of Cancer Therapy
Schmitt, C. A., Fridman, J. S., Yang, M., Lee, S., Baranov, E., Hoffman, R. M., & Lowe, S. W. (2002) · Cell · doi:10.1016/s0092-8674(02)00734-1 · Cited by 1,050 · see citing works
Self-citationp16INK4a induces an age-dependent decline in islet regenerative potential
Krishnamurthy, J., Ramsey, M. R., Ligon, K. L., Torrice, C., Koh, A., Bonner-Weir, S., & Sharpless, N. E. (2006) · Nature · doi:10.1038/nature05092 · Cited by 1,003 · cited 1× · see citing works
“…have been linked to selfrenewal of stem cells in the hematopoietic and neuronal systems (Bruggeman et al. 2005; Molofsky et al. 2005), and in fact, p16 accumulates in certain stem cells with age and acts to limit self-renewal (Janzen et al. 2006; Krishnamurthy et al. 2006; Molofsky et al. 2006).”
BackgroundIncreasing p16INK4a expression decreases forebrain progenitors and neurogenesis during ageing
Molofsky, A. V., Slutsky, S. G., Joseph, N. M., He, S., Pardal, R., Krishnamurthy, J., Sharpless, N. E., & Morrison, S. J. (2006) · Nature · doi:10.1038/nature05091 · Cited by 972 · cited 1× · see citing works
“…have been linked to selfrenewal of stem cells in the hematopoietic and neuronal systems (Bruggeman et al. 2005; Molofsky et al. 2005), and in fact, p16 accumulates in certain stem cells with age and acts to limit self-renewal (Janzen et al. 2006; Krishnamurthy et al. 2006; Molofsky et al. 2006).”
BackgroundSurvival signalling by Akt and eIF4E in oncogenesis and cancer therapy
Wendel, H., de Stanchina, E., Fridman, J. S., Malina, A., Ray, S., Kogan, S. C., Cordon‐Cardo, C., Pelletier, J., & Lowe, S. W. (2004) · Nature · doi:10.1038/nature02369 · Cited by 956 · see citing works
Self-citationLin, A. W., Barradas, M., Stone, J. C., van Aelst, L., Serrano, M., & Lowe, S. W. (1998) · Genes & Development · doi:10.1101/gad.12.19.3008 · Cited by 945 · see citing works
Self-citationWajapeyee, N., Serra, R. W., Zhu, X., Mahalingam, M., & Green, M. R. (2008) · Cell · doi:10.1016/j.cell.2007.12.032 · Cited by 903 · see citing works
Stems Cells and the Pathways to Aging and Cancer
Rossi, D. J., Jamieson, C. H. M., & Weissman, I. L. (2008) · Cell · doi:10.1016/j.cell.2008.01.036 · Cited by 895 · see citing works
(2002) · PubMed · Cited by 640 · see citing works
A novel role for high-mobility group A proteins in cellular senescence and heterochromatin formation
Narita, M., Narita, M., Krizhanovsky, V., Nuñez, S., Chicas, A., Hearn, S. A., Myers, M. P., & Lowe, S. W. (2006) · Cell · doi:10.1016/j.cell.2006.05.052 · Cited by 629 · see citing works
Self-citation(2003) · PubMed · Cited by 608 · see citing works
Molofsky, A. V., He, S., Bydon, M., Morrison, S. J., & Pardal, R. (2005) · Genes & Development · doi:10.1101/gad.1299505 · Cited by 586 · see citing works
Probing tumor phenotypes using stable and regulated synthetic microRNA precursors
Dickins, R., Hemann, M., Zilfou, J. T., Simpson, D. R., Ibarra, I., Hannon, G., & Lowe, S. (2005) · Nature Genetics · doi:10.1038/ng1651 · Cited by 561 · see citing works
Self-citationmicroRNAs join the p53 network — another piece in the tumour-suppression puzzle
He, L., He, X., Lowe, S. W., & Hannon, G. J. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2232 · Cited by 546 · see citing works
Self-citationHallmarks of senescence in carcinogenesis and cancer therapy
Shay, J. W., & Roninson, I. B. (2004) · Oncogene · doi:10.1038/sj.onc.1207518 · Cited by 502 · see citing works
A negative feedback signaling network underlies oncogene-induced senescence
Courtois-Cox, S., Genther Williams, S. M., Reczek, E. E., Johnson, B. W., McGillicuddy, L. T., Johannessen, C. M., Hollstein, P. E., MacCollin, M., & Cichowski, K. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.003 · Cited by 501 · see citing works
Inhibition of Experimental Liver Cirrhosis in Mice by Telomerase Gene Delivery
Rudolph, K. L., Chang, S., Millard, M., Schreiber-Agus, N., & DePinho, R. A. (2000) · Science · doi:10.1126/science.287.5456.1253 · Cited by 424 · see citing works
Nuclear factor‐κB and the hepatic inflammation‐fibrosis‐cancer axis†
Elsharkawy, A. M., & Mann, D. A. (2007) · Hepatology · doi:10.1002/hep.21802 · Cited by 400 · see citing works
Vaziri, H., West, M. D., Allsopp, R., Davison, T. S., Wu, Y., Arrowsmith, C. H., Poirier, G. G., & Benchimol, S. (1997) · The EMBO Journal · doi:10.1093/emboj/16.19.6018 · Cited by 384 · see citing works
Oncogene-Induced Cell Senescence — Halting on the Road to Cancer
Mooi, W. J., & Peeper, D. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmra062285 · Cited by 371 · see citing works
Bruggeman, S. W. M., Valk-Lingbeek, M. E., van der Stoop, P. P. M., Jacobs, J. J. L., Kieboom, K., Tanger, E., Hulsman, D., Leung, C., Arsenijevic, Y., Marino, S., et al. (2005) · Genes & Development · doi:10.1101/gad.1299305 · Cited by 315 · see citing works
Delmas, V., Beermann, F., Martinozzi, S., Carreira, S., Ackermann, J., Kumasaka, M. Y., Denat, L., GOODALL, J. C., Luciani, F., Virós, A., et al. (2007) · Genes & Development · doi:10.1101/gad.450107 · Cited by 312 · see citing works
A New Mutational aktivation in the PI3K Pathway
Brugge, J. S., Hung, M., & Mills, G. B. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.07.014 · Cited by 264 · see citing works
Fate-Mapping Evidence That Hepatic Stellate Cells Are Epithelial Progenitors in Adult Mouse Livers
Yang, L., Jung, Y., Omenetti, A., Witek, R. P., Choi, S. S., VanDongen, H. M. A., Huang, J., Alpini, G. D., & Diehl, A. M. (2008) · Stem Cells · doi:10.1634/stemcells.2008-0115 · Cited by 200 · see citing works
Denchi, E. L., Attwooll, C., Pasini, D., & Helin, K. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.7.2660-2672.2005 · Cited by 195 · see citing works
Role of Polycomb Group Proteins in Stem Cell Self-Renewal and Cancer
Gil, J., Bernard, D., & Peters, G. G. (2005) · DNA and Cell Biology · doi:10.1089/dna.2005.24.117 · Cited by 152 · see citing works
Narita, M., & Lowe, S. W. (2005) · Nature Medicine · doi:10.1038/nm0905-920 · Cited by 150 · see citing works
Self-citationARF functions as a melanoma tumor suppressor by inducing p53-independent senescence
Ha, L., Ichikawa, T., Anver, M. R., Dickins, R. A., Lowe, S. W., Sharpless, N. E., Krimpenfort, P., DePinho, R. A., Bennett, D. C., Sviderskaya, E. V., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611638104 · Cited by 144 · see citing works
Self-citationLymphocyte–hepatic stellate cell proximity suggests a direct interaction
Muhanna, N., Horani, A., Doron, S., & Safadi, R. (2007) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2007.03353.x · Cited by 70 · see citing works
BCR–ABL and CDKN2A: a dropped connection
Williams, R. T., & Sherr, C. J. (2008) · Nature reviews. Cancer · doi:10.1038/nrc2368-c1 · Cited by 17 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- Collado M Gil J Efeyan A Guerra C Schuhmacher AJ Barradas M Benguria A Zaballos A Flores JM Barbacid M Beach D Serrano M Tumour biology: Senescence in premalignant tumours Nature 2005 436 642 16079833
Cited by
Sorted by citations
Cellular Senescence: Defining a Path Forward
Gorgoulis, V., Adams, P. D., Alimonti, A., Bennett, D. C., Bischof, O., Bishop, C., Campisi, J., Collado, M., Evangelou, K., Ferbeyre, G., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.005 · Cited by 3,225 · see citing works
Self-citationProgrammed cell senescence during mammalian embryonic development
Muñoz-Espín, D., Cañamero, M., Maraver, A., Gómez-López, G., Contreras, J., Murillo-Cuesta, S., Rodríguez-Baeza, A., Varela-Nieto, I., Ruberte, J., Collado, M., et al. (2013) · Cell · doi:10.1016/j.cell.2013.10.019 · Cited by 1,428 · see citing works
Senescence-associated reprogramming promotes cancer stemness
Milanovic, M., Fan, D. N. Y., Belenki, D., Däbritz, J. H. M., Zhao, Z., Yu, Y., Dörr, J. R., Dimitrova, L., Lenze, D., Monteiro Barbosa, I. A., et al. (2018) · Nature · doi:10.1038/nature25167 · Cited by 1,131 · see citing works
Hall, B. M., Balan, V., Gleiberman, A. S., Strom, E., Krasnov, P., Virtuoso, L. P., Rydkina, E., Vujcic, S., Balan, K., Gitlin, I., et al. (2016) · Aging · doi:10.18632/aging.100991 · Cited by 357 · see citing works
Cellular senescence and the aging brain
Chinta, S. J., Woods, G., Rane, A., Demaria, M., Campisi, J., & Andersen, J. K. (2015) · Experimental Gerontology · doi:10.1016/j.exger.2014.09.018 · Cited by 282 · see citing works
Neutrophil extracellular traps target senescent vasculature for tissue remodeling in retinopathy
Binet, F., Cagnone, G., Crespo-Garcia, S., Hata, M., Neault, M., Dejda, A., Wilson, A. M., Buscarlet, M., Mawambo, G. T., Howard, J. P., et al. (2020) · Science · doi:10.1126/science.aay5356 · Cited by 283 · see citing works
The promises and perils of p53
Krizhanovsky, V., & Lowe, S. W. (2009) · Nature · doi:10.1038/4601085a · Cited by 274 · see citing works
Self-citationCellular senescence controls fibrosis in wound healing
Jun, J.-I., & Lau, L. F. (2010) · Aging · doi:10.18632/aging.100201 · Cited by 255 · see citing works
Granule exocytosis mediates immune surveillance of senescent cells
Sagiv, A., Biran, A., Yon, M., Simon, J., Lowe, S. W., & Krizhanovsky, V (2013) · Oncogene · doi:10.1038/onc.2012.206 · Cited by 240 · see citing works
Self-citationContext-dependent effects of cellular senescence in cancer development.
Lecot, P., Alimirah, F., Desprez, P.-Y., Campisi, J., & Wiley, C. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.115 · Cited by 183 · see citing works
Chinta, S. J., Lieu, C. A., DeMaria, M., Laberge, R. ‐., Campisi, J., & Andersen, J. K. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12029 · Cited by 165 · see citing works
“For example, chemokines or cytokines secreted by senescent cells can recruit natural killer cells, thus facilitating the removal of senescent cells and neighbouring tumour cells [50, 51]; this process is termed ‘senescence surveillance’ [36].”
Cellular senescence impact on immune cell fate and function
Vicente, R., Mausset-Bonnefont, A.-L., Jorgensen, C., Louis-Plence, P., & Brondello, J.-M. (2016) · Aging Cell · doi:10.1111/acel.12455 · Cited by 151 · see citing works
Maciel-Barón, L. A., Morales-Rosales, S. L., Aquino-Cruz, A. A., Triana-Martínez, F., Galván-Arzate, S., Luna-López, A., González-Puertos, V. Y., López-Díazguerrero, N. E., Torres, C., & Königsberg, M. (2016) · AGE · doi:10.1007/s11357-016-9886-1 · Cited by 128 · see citing works
Cellular senescence links aging and diabetes in cardiovascular disease
Shakeri, H., Lemmens, K., Gevaert, A. B., De Meyer, G. R. Y., & Segers, V. F. M. (2018) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00287.2018 · Cited by 134 · see citing works
Burton, D. G. A., Matsubara, H., & Ikeda, K. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2010.07.005 · Cited by 121 · see citing works
Senescent Cells and Their Secretory Phenotype as Targets for Cancer Therapy
Velarde, M. C., Demaria, M., & Campisi, J. (2013) · Interdisciplinary Topics in Gerontology and Geriatrics · doi:10.1159/000343572 · Cited by 112 · see citing works
Senescent hepatic stellate cells promote liver regeneration through IL-6 and ligands of CXCR2
Cheng, N., Kim, K.-H., & Lau, L. F. (2022) · JCI Insight · doi:10.1172/jci.insight.158207 · Cited by 87 · see citing works
“In the liver, recent studies have found that cellular senescence in parenchymal cells can be detrimental to regeneration (19, 20), but senescence in hepatic stellate cells (HSCs) may limit and reduce fibrosis (21, 22).”
Basisty, N., Kale, A., Patel, S., Campisi, J., & Schilling, B. (2020) · Expert Review of Proteomics · doi:10.1080/14789450.2020.1766976 · Cited by 69 · see citing works
Senescence determines the fate of activated rat pancreatic stellate cells
Fitzner, B., Müller, S., Walther, M., Fischer, M., Engelmann, R., Müller‐Hilke, B., Pützer, B. M., Kreutzer, M., Nizze, H., & Jaster, R. (2012) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2012.01573.x · Cited by 66 · see citing works
Innate immunity and cellular senescence: The good and the bad in the developmental and aged brain
Santoro, A., Spinelli, C. C., Martucciello, S., Nori, S. L., Capunzo, M., Puca, A. A., & Ciaglia, E. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mr0118-003r · Cited by 50 · see citing works
NF90 coordinately represses the senescence-associated secretory phenotype
Tominaga-Yamanaka, K., Abdelmohsen, K., Martindale, J. L., Yang, X., Taub, D. D., & Gorospe, M. (2012) · Aging · doi:10.18632/aging.100497 · Cited by 49 · see citing works
Quantitative model of cell cycle arrest and cellular senescence in primary human fibroblasts
Schäuble, S., Klement, K., Marthandan, S., Münch, S., Heiland, I., Schuster, S., Hemmerich, P., & Diekmann, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042150 · Cited by 35 · see citing works
- Authors
- Krizhanovsky, V., Xue, W., Zender, L., Yon, M., Hernando, E., & Lowe, S. W.
- Affiliations
- Cold Spring Harbor Laboratory (US)
- Universidade de São Paulo (BR)
- New York University (US)
- Howard Hughes Medical Institute (US)
- Venue
- Cold Spring Harbor Symposia on Quantitative Biology
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2008-01-01
- Volume
- 73
- Issue
- 0
- Pages
- 513-522
- ISSN
- 0091-7451 (ISSN-L)
- 1943-4456
- PMC
- PMC3285266
- OpenAlex
- W2138631175
- Semantic Scholar
- 4cc2055fb20e58a4bb05876dcbdf93d230afc3bd
- Cited by
- 138
- References
- 52
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 8 · 2023: 12 · 2022: 10 · 2021: 6 · 2020: 10 · 2019: 6 · 2018: 7 · 2017: 5 · 2016: 8 · 2015: 6 · 2014: 7 · 2013: 7 · 2012: 13
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cold Spring Harbor Symposia on Quantitative Biology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Cold Spring Harbor Laboratory Institutional Repository (Cold Spring Harbor Laboratory) (acceptedVersion)
- Funders
- Howard Hughes Medical Institute
- Leukemia and Lymphoma Society
- Cold Spring Harbor Laboratory
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- National Institutes of Health
- National Institute on Aging (AG-16379, R01AG016379)
- National Cancer Institute (P30CA008748)
- Topics
- Health Sciences › Medicine › Physiology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- cellular senescence, tumor suppression, stem cell biology, hepatoblasts, p53 reactivation, hepatic stellate cells, liver fibrosis, cell immortalization, senescence-associated secretory phenotype, wound healing
- MeSH terms
- Animals, Cell Transformation, Neoplastic, Humans, Immunity, Innate, Liver Cirrhosis, Liver Neoplasms, Experimental, Neoplasms, Oncogenes, Stem Cells, Wound Healing, Signal Transduction, Gene Expression, Genes, p53, Cellular Senescence, Phosphatidylinositol 3-Kinases, Cell Proliferation, Oncogene Protein v-akt, Mice, Hepatic Stellate Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-06.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-06.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review